自身免疫与自身炎症重叠的类风湿关节炎:罕见但重要的亚组
本文描述5例经典自身抗体相关类风湿关节炎(RA)患者,临床、遗传和治疗反应提示合并系统性自身炎症性疾病(SAID)。这些患者有多关节炎和自身抗体/共享表位阳性,并有突发严重自限性发热和浆膜炎发作,存在自身炎症通路的突变或单核苷酸多态性。常规DMARD治疗反应差,部分对秋水仙碱或白介素1通路阻断反应良好。
要点
- 部分RA患者可重叠自身炎症特征,表现为突发自限性发热和浆膜炎。
- 此类患者常携带自身炎症通路基因突变或单核苷酸多态性。
- 常规DMARD反应差,秋水仙碱或IL-1阻断可能有效。
核心结论
- 一部分RA病例具有自身免疫与自身炎症混合的表型和基因型,并影响治疗选择。
研究设计与样本
- 描述性病例系列,纳入5例临床重叠RA与SAID特征的患者。
主要发现
- 5例患者均有RA与SAID重叠特征,包括多关节炎和自身抗体/共享表位阳性。
- 患者出现突发严重自限性发作,包括发热和浆膜炎。
- 检测到自身炎症通路中已知的突变或单核苷酸多态性。
- 多数对常规DMARD治疗反应不佳,部分对秋水仙碱或白介素1通路阻断反应良好。
临床怎么用
- 对常规DMARD反应不佳且反复突发发热、浆膜炎的RA患者,应警惕自身炎症重叠可能。
- 识别此类亚组可考虑秋水仙碱或白介素1通路阻断治疗。
局限性
- 仅为5例病例描述,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
At the population level, rheumatoid arthritis (RA) is generally viewed as autoimmune in nature with a small subgroup of cases having a palindromic form or systemic autoinflammatory disorder (SAID) phenotype. Herein, we describe resistant cases of classical autoantibody associated RA that had clinical, genetic and therapeutic responses indicative of coexistent autoinflammatory disease. Five patients with clinically overlapping features between RA and SAID including polysynovitis and autoantibody/shared epitope positivity, and who had abrupt severe self-limiting attacks including fevers and serositis, are described. Mutations or single nucleotide polymorphisms in recognised autoinflammatory pathways were evident. Generally, these cases responded poorly to conventional Disease-modifying anti-rheumatic drugs (DMARD) treatment with some excellent responses to colchicine or interleukin 1 pathway blockade. A subgroup of RA cases have a mixed autoimmune-autoinflammatory phenotype and genotype with therapeutic implications.
引用
- Savic S, Mistry A, Wilson AG, et al. Autoimmune-autoinflammatory rheumatoid arthritis overlaps: a rare but potentially important subgroup of diseases. RMD Open. 2017. PMID: 29177082. doi:10.1136/rmdopen-2017-000550
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。